Helicobacter pylori recurrence and infection rate in Israeli adults

Digestive Diseases and Sciences

Volumn 53, Issue 5, 2008, Pages 1211-1214

  Niv, Yaron ^a   Hazazi, Rachel ^a   Waked, Amal ^a   Lederfein, Tami ^a   Achiel, Karin ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Eradication; Helicobacter pylori; Re infection; Recrudescence; Recurrence

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBON 13; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DATA BASE; DEVELOPING COUNTRY; DIAGNOSTIC VALUE; DYSPEPSIA; ERADICATION THERAPY; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INFECTION RATE; ISRAEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; RECURRENCE RISK; RECURRENT INFECTION; REINFECTION; STATISTICAL SIGNIFICANCE; UREA BREATH TEST; VALIDATION PROCESS;

ADULT; AMOXICILLIN; ANTI-INFECTIVE AGENTS; ANTI-ULCER AGENTS; BREATH TESTS; CHI-SQUARE DISTRIBUTION; CLARITHROMYCIN; DRUG THERAPY, COMBINATION; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; ISRAEL; MALE; MIDDLE AGED; OMEPRAZOLE; PROGNOSIS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RECURRENCE;

EID: 41949137522     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-007-0016-x     Document Type: Article

References (23)

1. Parsonnet J (1995) The incidence of Helicobacter pylori infection. Aliment Pharmacol Ther 9[Suppl 2]:45-51
2. Williams MP, Pounder RE (1999) Helicobacter pylori: from the benign to the malignant. Am J Gastroenterol 94[Suppl]:s11-s16
3. Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, Hunt R, Rokkas T, Vakil N, Kuipers EJ (2007) Current concepts in the management of Helicobacter pylori infection: the Maastricht III consensus report. Gut 56:772-781
4. Neil GA, Suchower LJ, Ronca PD et al (1997) Time of Helicobacter pylori eradication assessment following treatment. Helicobacter 2:13-20
5. Gisbert JP (2005) The recurrence of Helicobacter pylori infection: incidence and variables influencing it. A critical review. Am J Gastroenterol 100:2083-2099
6. Xia HX, Talley NJ, Keane CT et al (1997) Recurrence of Helicobacter pylori infection after successful eradication: nature and possible causes. Dig Dis Sci 42:1821-1834
7. 13C-urea breath test for validation of successful Helicobacter pylori eradication. Evaluation of 1986 patients in a Central laboratory. Israel Med Assoc J 5:98-100
8. 13C-urea breath test, referral patterns and results in children. J Clin Gastroenterol 37:142-146
9. 13C-UBT in the elderly population. Dig Dis Sci 49:1840-1844
10. 13C-UBT for validation of successful Helicobacter pylori eradication: study of 5885 Israeli patients. Dig Dis Sci 50:1513-1516
11. Graham DY, Lew GM, Klein PD et al (1992) Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann Intern Med 116:705-708
12. Cutler AF, Schubert TT (1993) Long-term Helicobacter pylori recurrence after successful eradication with triple therapy. Am J Gastroenterol 88:1359-1361
13. Abu-Mahfouz MZ, Prasad VM, Santogade P et al (1997) Helicobacter pylori recurrence after successful eradication: 5-year follow-up in the United States. Am J Gastroenterol 92:2025-2028
14. Gisbert JP, Pajares JM, Garcia-Valriberas R et al (1998) Recurrence of Helicobacter pylori infection after eradication: incidence and variables influencing it. Scand J Gastroenterol 33:1144-1151
15. Fraser AG, Schreuder V, Chua LE et al (1998) Follow-up after successful eradication of Helicobacter pylori: symptoms and reinfection. J Gastroenterol Hepatol 13:555-559
16. Gisbert JP, Arata IG, Boixeda D et al (2002) Role of partner's infection in reinfection after Helicobacter pylori eradication. Eur J Gastroenterol Hepatol 14:865-871
17. Adachi M, Mizuno M, Yokota K et al (2002) Reinfection rate following effective therapy against Helicobacter pylori infection in Japan. J Gastroenterol Hepatol 17:27-31
18. Okimoto T, Murakami K, Sato R et al (2003) Is the recurrence of Helicobacter pylori infection after eradication therapy resultant from recrudescence or reinfection, in Japan. Helicobacter 8:186-191
19. Rodriguez BJG, Feria MR, Montes MJG et al (2004) Incidence and factors influencing in Helicobacter pylori infection recurrence. Rev Esp Enferm Dig 96:620-627
20. Gisbert JP, Luna M, Gomez B et al (2006) Recurrence of Helicobacter pylori infection after several eradication therapies: long-term follow-up of 1000 patients. Alim Pharmacol Ther 23:713-719
21. Peitz U, Hackelsberger A, Malfertheiner P (1999) A practical approach to patients with refractory Helicobacter pylori infection, or who are re-infected after standard therapy. Drugs 57:905-920
22. van der Hulst RW, Rauws EA, Koycu B et al (1997) Helicobacter pylori reinfection is virtually absent after successful eradication. J Infect Dis 176:196-200
23. 13C-urea breath test values and response to first line and rescue Helicobacter pylori eradication therapies? Dig Liver Dis 38:254-259